Tonix Pharmaceuticals
TNXP
#8660
Rank
NZ$0.34 B
Marketcap
NZ$21.74
Share price
-8.79%
Change (1 day)
-64.79%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2025 (TTM): -NZ$0.17 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.29 Million. In 2024 the company made an earning of -NZ$0.13 Billion, an increase over its 2023 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.17 Billion28.84%
2024 -NZ$0.13 Billion-36.5%
2023 -NZ$0.21 Billion5.61%
2022 -NZ$0.2 Billion21.43%
2021 -NZ$0.16 Billion82.76%
2020 -NZ$85.98 Million75.22%
2019 -NZ$49.08 Million9.52%
2018 -NZ$44.81 Million23.63%
2017 -NZ$36.25 Million-45.36%
2016 -NZ$66.34 Million-19.09%
2015 -NZ$81.99 Million74.15%
2014 -NZ$47.08 Million153.99%
2013 -NZ$18.54 Million
2011 -NZ$8.95 Million29538.74%
2010 -NZ$0.04 Million-42.58%
2009 -NZ$0.06 Million46.05%
2008 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-NZ$39.57 Million-75.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$60.69 M-137.16%๐Ÿ‡บ๐Ÿ‡ธ USA